Aspen Pharmacare Holdings Ltd

Price Chart

Risk-Adjusted Performance

Also Listed On

Aspen Pharmacare Holdings Ltd (APN) Price Performance

Aspen Pharmacare Holdings Ltd (APN) trades on JSE in ZAc. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at ZAc13050.00, down 2.14% from the previous close.

Over the past year, APN has traded between a low of ZAc9100.00 and a high of ZAc15811.96. The stock has lost 17.5% over this period. It is currently 17.5% below its 52-week high.

Aspen Pharmacare Holdings Ltd has a market capitalization of $58.48B and a dividend yield of 0.02%.

About Aspen Pharmacare Holdings Ltd

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.